Bath & Body Works (NYSE:BBWI) Given New $39.00 Price Target at JPMorgan Chase & Co.

Bath & Body Works (NYSE:BBWI) had its price objective lifted by JPMorgan Chase & Co. from $35.00 to $39.00 in a research report report published on Tuesday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Other analysts have also issued research reports about the stock. Robert W. Baird lowered their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. BMO Capital Markets reaffirmed an “outperform” rating and set a $50.00 price target (down from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Evercore ISI decreased their price objective on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft cut their target price on Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a report on Monday, August 26th. Finally, Barclays boosted their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. According to MarketBeat, Bath & Body Works presently has an average rating of “Moderate Buy” and an average price target of $41.88.

Bath & Body Works Stock Performance

NYSE:BBWI opened at $36.29 on Tuesday. The company has a market capitalization of $7.86 billion, a PE ratio of 8.84, a P/E/G ratio of 1.35 and a beta of 1.79. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The company has a 50 day simple moving average of $31.05 and a two-hundred day simple moving average of $35.65.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Research analysts predict that Bath & Body Works will post 3.24 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.20%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio is presently 19.51%.

Insider Buying and Selling

In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of Bath & Body Works stock in a transaction on Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the purchase, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Bath & Body Works

Hedge funds and other institutional investors have recently made changes to their positions in the stock. CWM LLC increased its holdings in Bath & Body Works by 6.6% during the second quarter. CWM LLC now owns 5,072 shares of the company’s stock worth $198,000 after buying an additional 314 shares during the last quarter. Northwest Bank & Trust Co grew its position in shares of Bath & Body Works by 2.5% during the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after acquiring an additional 315 shares during the period. DekaBank Deutsche Girozentrale grew its position in shares of Bath & Body Works by 1.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after acquiring an additional 322 shares during the period. TD Private Client Wealth LLC increased its stake in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares during the last quarter. Finally, Citizens & Northern Corp raised its holdings in shares of Bath & Body Works by 1.7% in the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock worth $1,151,000 after purchasing an additional 487 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.